Molbio Diagnostics Limited

Molbio Diagnostics Limited Enabling better medicine through precise, rapid, cost-effective molecular diagnosis at the point of

Enabling better medicine through precise, rapid, cost- effective molecular diagnosis at the point of care.

To***co doesn't just destroy your lungs. It opens the door for TB.On World No To***co Day - a reminder that TB eliminati...
31/05/2026

To***co doesn't just destroy your lungs. It opens the door for TB.

On World No To***co Day - a reminder that TB elimination starts long before diagnosis.

***coDay

28/05/2026

Early detection is one of the strongest defenses against cervical cancer. Screening, in time, can change everything.

This International Day of Action for Women's Health, we are reminded that access to that early window must reach every woman, wherever she is. Solutions like Truenat HPV HR Plus are part of a wider effort to make point-of-care cervical cancer testing more accessible across underserved communities.

We recently had the chance to sit down with Sadhna Jadon, President & Senior Manager, NCPI+, and listen to her journey as a PLHIV (persons living with HIV), and what awareness and timely screening can mean for women all around the world.

19/05/2026

On Mother's Day, 13 women in Margao, Goa walked in for a breast health screening - many for the very first time.

Using iBreastExam, a painless and portable breast screening device, the camp at Healing Touch Centre made screening feel accessible and approachable. One positive finding was detected and flagged for follow-up — a reminder of why regular screening matters.

Thank you to the Rotary Club of Margao Sunrise and Healing Touch Centre for making women's health the centrepiece of this Mother's Day.



Rotary Club | iBreastExam

"With affordable NPOC tests now being manufactured in the global south, it is exciting to see Indian innovations that ca...
15/05/2026

"With affordable NPOC tests now being manufactured in the global south, it is exciting to see Indian innovations that can be used with tongue swabs. India can now scale them up to replace the old smear microscopy."

— Dr. Madhukar Pai, Chair of Global and Public Health, McGill University

Truenat was built in India, for the settings where the TB burden is highest. That work is slowly being recognised, as it continues to shape the point of care diagnosis in over 85 countries.

Read the full article- https://timesofindia.indiatimes.com/life-style/health-plus/new-molecular-tests-to-change-how-tb-is-detected/articleshow/130093073.cms

Malaria has been curable for decades. It still kills over 610,000 people a year.Part of that gap lives in the diagnosis....
25/04/2026

Malaria has been curable for decades. It still kills over 610,000 people a year.

Part of that gap lives in the diagnosis.

Some P. falciparum strains carry genetic deletions that make them invisible to HRP2-based rapid tests — the most widely deployed malaria diagnostics in the world.

P. vivax takes a different route. It retreats into the liver, persisting long after symptoms resolve — relapsing weeks, months, or years later without a single new mosquito bite.

In parts of Asia, the Amazon basin, and the Horn of Africa, both parasites co-exist. That mixed infection is frequently missed by conventional diagnostics.

Truenat Malaria Pv/Pf detects both — at the point of care, where it matters most.

Diagnostics that bring the lab to you.Testing that asks less of the earth.Care that's closer to people - and kinder to t...
22/04/2026

Diagnostics that bring the lab to you.
Testing that asks less of the earth.

Care that's closer to people - and kinder to the planet.

This Earth Day, we're thinking about the full picture of health. Not just who gets access to a diagnosis - but what kind of world they're diagnosed into.

Truenat travels to the last mile - to villages, valleys, and communities far from any centralised lab. Less infrastructure. Less footprint. More care, where it's needed most.

Dust. Distance. Uncertainty.For families in Zimbabwe's most remote regions, these were the conditions of a TB diagnosis ...
17/04/2026

Dust. Distance. Uncertainty.

For families in Zimbabwe's most remote regions, these were the conditions of a TB diagnosis — days of travel to reach a clinic, weeks of waiting for results, and the quiet heartbreak of patients who never returned for them.

Something is shifting.

Decentralised molecular testing has collapsed a two-week wait into a few hours. Mobile screening initiatives are moving closer to the people who need them most — including in the Zambezi Valley, where a same-day diagnosis can mean the difference between treatment and silence.

Health worker Martha Sibanda stands at the centre of this transformation. Her work. Her community. Her story.

Read the full impact story by visiting this link: https://www.molbiodiagnostics.com/through-dust-and-hope-zimbabwes-tb-revolution/


29/03/2026

Tuberculosis remains a major public health challenge in the Philippines. Spread across over 7,000 islands, access to timely diagnosis remains one of the most significant barriers.

Since its introduction in 2021, has become part of the country’s response—bringing testing closer to where it’s needed most.

We spoke to 𝗧𝗲𝗼𝗱𝗼𝗿𝗼 𝗝. 𝗛𝗲𝗿𝗯𝗼𝘀𝗮, 𝗦𝗲𝗰𝗿𝗲𝘁𝗮𝗿𝘆 𝗼𝗳 𝗛𝗲𝗮𝗹𝘁𝗵, 𝗣𝗵𝗶𝗹𝗶𝗽𝗽𝗶𝗻𝗲𝘀, to understand the role it is playing in decentralising access to care.

Because in a country defined by distance, access isn’t just important—it’s everything.

25/03/2026

We take decentralisation seriously.

In partnership with TABIB and the Lung Diseases Centre of Azerbaijan, Molbio Diagnostics has deployed a mobile diagnostic van in Baku, bringing end-to-end TB screening and diagnostics closer to the communities that need them most.

Equipped with Truenat and Prorad Atlas, the van enables molecular diagnostics and portable X-ray at the point of care—extending access beyond conventional health infrastructure.

This marks a meaningful step forward in our commitment to making precise, rapid diagnostics available at the point of care — wherever that may be.

Recently, in Ecuador, Truenat MTB Plus/RIF was evaluated against GeneXpert MTB/XDR across pulmonary and extrapulmonary s...
22/03/2026

Recently, in Ecuador, Truenat MTB Plus/RIF was evaluated against GeneXpert MTB/XDR across pulmonary and extrapulmonary samples under real-world conditions.

The insights from the study will be presented at the 𝗖𝘂𝗿𝘀𝗼 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝗰𝗶𝗼𝗻𝗮𝗹 𝗱𝗲 𝗔𝗰𝘁𝘂𝗮𝗹𝗶𝘇𝗮𝗰𝗶𝗼𝗻 𝗲𝗻 𝗧𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀 𝟮𝟬𝟮𝟲.

Led by 𝗗𝗿. 𝗚𝗿𝗲𝘁𝗮 𝗙𝗿𝗮𝗻𝗰𝗼 𝗦𝗼𝘁𝗼𝗺𝗮𝘆𝗼𝗿, the session explores how both molecular diagnostic platforms perform across varied sample types, reflecting the practical challenges of TB diagnosis in diverse care settings.

The findings will be discussed on 𝟮𝟯 𝗠𝗮𝗿𝗰𝗵 (𝟭𝟬:𝟬𝟬–𝟭𝟬:𝟯𝟬 𝗵𝗿𝘀, 𝗖𝗦𝗧 | 𝟮𝟬:𝟬𝟬 - 𝟮𝟬:𝟯𝟬 𝗵𝗿𝘀, 𝗜𝗦𝗧).

𝗪𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗹𝗶𝘃𝗲 𝗼𝗻 𝗬𝗼𝘂𝗧𝘂𝗯𝗲: https://www.youtube.com/live/Xdw02g-bwjI?si=eoLo5Qkd-yJR_EDX

CTR Scientific

Address

Goa

Website

Alerts

Be the first to know and let us send you an email when Molbio Diagnostics Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Molbio Diagnostics Limited:

Shortcuts

Share

Category